IGF1R and neoplasm: As SUMO1 modification is critical for IGF‐1R's transactivating effects and nuclear receptor is linked to adverse clinical outcome and tumor biological properties, we, here, sought to investigate whether the SUMOylation status of IGF1R may affect cell proliferation.